首页> 美国卫生研究院文献>Japanese Clinical Medicine >Familial Dysalbuminemic Hyperthyroxinemia in a Japanese Man Caused by a Point Albumin Gene Mutation (R218P)
【2h】

Familial Dysalbuminemic Hyperthyroxinemia in a Japanese Man Caused by a Point Albumin Gene Mutation (R218P)

机译:由点白蛋白基因突变(R218P)引起的日本男子家族性水合白蛋白过高甲状腺素血症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Familial dysalbuminemic hyperthyroxinemia (FDH) is a familial autosomal dominant disease caused by mutation in the albumin gene that produces a condition of euthyroid hyperthyroxinemia. In patients with FDH, serum-free thyroxine (FT4) and free triiodothyronine (FT3) concentrations as measured by several commercial methods are often falsely increased with normal thyrotropin (TSH). Therefore, several diagnostic steps are needed to differentiate TSH-secreting tumor or generalized resistance to thyroid hormone from FDH. We herein report a case of a Japanese man born in Aomori prefecture, with FDH caused by a mutant albumin gene (R218P). We found that a large number of FDH patients reported in Japan to date might have been born in Aomori prefecture and have shown the R218P mutation. In conclusion, FDH needs to be considered among the differential diagnoses in Japanese patients born in Aomori prefecture and showing normal TSH levels and elevated FT4 levels.
机译:家族性dysalbuminemic高甲状腺素血症(FDH)是家族性常染色体显性疾病,由白蛋白基因突变引起,可导致甲状腺功能正常。在FDH患者中,通过正常商业促甲状腺激素(TSH),通过几种商业方法测量的无血清甲状腺素(FT4)和游离三碘甲状腺素(FT3)浓度通常会错误地增加。因此,需要一些诊断步骤来区分分泌TSH的肿瘤或FDH对甲状腺激素的普遍耐药性。我们在这里报告了一个日本男子在青森县出生的案例,其中由突变白蛋白基因(R218P)引起的FDH。我们发现,迄今在日本报道的大量FDH患者可能出生于青森县,并显示出R218P突变。总而言之,在青森县出生的日本患者中,TSH水平正常且FT4水平升高,因此在鉴别诊断中需要考虑FDH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号